Verona Pharma plc (VRP.L) (LON:VRP) Stock Price Crosses Below Two Hundred Day Moving Average – Here’s What Happened

Verona Pharma plc (VRP.L) (LON:VRP)’s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 55 ($0.70) and traded as low as GBX 50 ($0.63). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.70), with a volume of 70,791 shares traded.

Verona Pharma plc (VRP.L) Stock Up 5.8 %

The firm’s 50-day moving average is GBX 55 and its 200 day moving average is GBX 55. The firm has a market capitalization of £228.00 million and a PE ratio of -1.68. The company has a debt-to-equity ratio of 6.85, a quick ratio of 2.47 and a current ratio of 2.99.

About Verona Pharma plc (VRP.L)

Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.